Healthcare -
Biotechnology - NASDAQ - US
$ 5.4
9.09 %
$ 46.3 M
Market Cap
-0.39
P/E
KPTI - CASH FROM OPERATIONS
Cash from Operations KPTI - Karyopharm Therapeutics Inc.
-127 M
LAST VALUE
7.67%
2 YEAR CAGR
7.75%
5 YEAR CAGR
-9.50%
10 YEAR CAGR